JP2025503953A5 - - Google Patents

Info

Publication number
JP2025503953A5
JP2025503953A5 JP2024544377A JP2024544377A JP2025503953A5 JP 2025503953 A5 JP2025503953 A5 JP 2025503953A5 JP 2024544377 A JP2024544377 A JP 2024544377A JP 2024544377 A JP2024544377 A JP 2024544377A JP 2025503953 A5 JP2025503953 A5 JP 2025503953A5
Authority
JP
Japan
Prior art keywords
alkyl
alkylene
aryl
cycloalkyl
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024544377A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025503953A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/011520 external-priority patent/WO2023146897A1/en
Publication of JP2025503953A publication Critical patent/JP2025503953A/ja
Publication of JP2025503953A5 publication Critical patent/JP2025503953A5/ja
Pending legal-status Critical Current

Links

JP2024544377A 2022-01-26 2023-01-25 2-置換チアゾールhsd17b13阻害剤およびその使用 Pending JP2025503953A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
IN202211004338 2022-01-26
IN202211004338 2022-01-26
US202263342786P 2022-05-17 2022-05-17
US63/342,786 2022-05-17
US202263377421P 2022-09-28 2022-09-28
US63/377,421 2022-09-28
PCT/US2023/011520 WO2023146897A1 (en) 2022-01-26 2023-01-25 2-substituted thiazole hsd17b13 inhibitors and uses thereof

Publications (2)

Publication Number Publication Date
JP2025503953A JP2025503953A (ja) 2025-02-06
JP2025503953A5 true JP2025503953A5 (https=) 2026-02-02

Family

ID=87472401

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024544377A Pending JP2025503953A (ja) 2022-01-26 2023-01-25 2-置換チアゾールhsd17b13阻害剤およびその使用

Country Status (11)

Country Link
US (1) US20250100993A1 (https=)
EP (1) EP4469451A4 (https=)
JP (1) JP2025503953A (https=)
KR (1) KR20240142476A (https=)
CN (1) CN119032090A (https=)
AU (1) AU2023213627A1 (https=)
CA (1) CA3249582A1 (https=)
IL (1) IL314415A (https=)
MX (1) MX2024009117A (https=)
TW (1) TW202337449A (https=)
WO (1) WO2023146897A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021377248B2 (en) 2020-11-13 2025-12-18 Inipharm, Inc. Dichlorophenol hsd17b13 inhibitors and uses thereof
PL4514782T3 (pl) 2022-05-19 2026-02-23 Astrazeneca Ab Związki amidoheteroaromatyczne przydatne w leczeniu chorób wątroby
WO2025024682A1 (en) * 2023-07-26 2025-01-30 Inipharm, Inc. Methods of using dichlorophenol hsd17b13 inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0513702D0 (en) * 2005-07-04 2005-08-10 Sterix Ltd Compound
EP4185381A4 (en) * 2020-07-24 2024-08-21 Inipharm, Inc. Thiophene hsd17b13 inhibitors and uses thereof
AU2021377248B2 (en) * 2020-11-13 2025-12-18 Inipharm, Inc. Dichlorophenol hsd17b13 inhibitors and uses thereof
EP4319872A4 (en) * 2021-04-05 2025-03-12 Inipharm, Inc. Thiazole/isothiazole hsd17b13 inhibitors and uses thereof

Similar Documents

Publication Publication Date Title
JP2025503953A5 (https=)
JP2024520481A5 (https=)
JP2024541910A5 (https=)
JP2023537271A5 (https=)
JP2023535453A5 (https=)
JP2024514837A5 (https=)
JP2025507292A5 (https=)
JP2024050527A5 (https=)
JP2025502943A5 (https=)
JP2024514223A5 (https=)
JP2019034943A5 (https=)
JP2024542969A5 (https=)
JP2008510691A5 (https=)
JP2010501584A5 (https=)
JP2025505994A5 (https=)
JP2017536395A5 (https=)
JP2023549494A5 (https=)
JP2025513882A5 (https=)
HRP20150838T1 (hr) Sastavi koji sadrže modulatore receptora sfingozin 1 fosfata (s1p)
JP2018518537A5 (https=)
JP2020502047A5 (https=)
JP2023553835A5 (https=)
JP2019516713A5 (https=)
JP2017537940A5 (https=)
JP2021527125A5 (https=)